IL-3 receptor beta chain promotes the oncogenic potential of FLT3-ITD

被引：0
|
作者：
Charlet, A. [1 ]
Kappenstein, M. J. [1 ]
Rummelt, C. [1 ]
Endres, C. [1 ]
Duyster, J. [1 ,2 ]
von Bubnoff, N. [1 ,2 ,3 ]
机构：
[1] Uniklin Freiburg, Hamatol Onkol & Stammzelltransplantat, Innere Med 1, Freiburg, Germany
[2] DKTK, Freiburg, Germany
[3] Univ Klinikum Schleswig Holstein, Klin Hamatol & Onkol, Campus Lubeck, Lubeck, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P354
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [1] Significance of the IL-3 Receptor Beta Chain (IL-3Rbc) for FLT3-ITD Dependent Oncogeneic Signaling in AML
    Rummelt, Christoph
    Gorantla, Sivahari Prasad
    Keye, Philip
    Klaesener, Kathrin
    Rao, Venkatesh
    Peschel, Christian
    Reth, Michael
    Duyster, Justus
    von Bubnoff, Nikolas
    BLOOD, 2015, 126 (23)
  • [2] Significance of the IL-3 receptor beta chain (IL-3Rβc) for FLT3-ITD dependent oncogeneic signaling in AML
    Rummelt, C.
    Gorantla, S. P.
    Klaesener, K.
    Keye, P.
    Rao, V
    Reth, M.
    Duyster, J.
    von Bubnoff, N.
    Oncology Research and Treatment, 2015, 38 : 160 - 161
  • [3] FLT3-ITD interacts with and phosphorylates IL-3β, and JAK1/2 dependent IL-3β activation bypasses FLT3-ITD in FLT3 kinase independent inhibitor resistance in vitro: Evidence for the significance of IL-3β for FLT3-ITD dependent oncogeneic signaling in AML
    Rummelt, C. A.
    Gorantla, S. P.
    Sigl, M.
    Saenger, J.
    Peschel, C.
    Duyster, J.
    Von Bubnoff, N.
    ONKOLOGIE, 2012, 35 : 89 - 89
  • [4] The IL-3, IL-5, and GM-CSF common receptor beta chain mediates oncogenic activity of FLT3-ITD-positive AML
    Anne Charlet
    Max Kappenstein
    Philip Keye
    Kathrin Kläsener
    Cornelia Endres
    Teresa Poggio
    Sivahari P. Gorantla
    Stefanie Kreutmair
    Jana Sänger
    Anna L. Illert
    Cornelius Miething
    Michael Reth
    Justus Duyster
    Christoph Rummelt
    Nikolas von Bubnoff
    Leukemia, 2022, 36 : 701 - 711
  • [5] The IL-3, IL-5, and GM-CSF common receptor beta chain mediates oncogenic activity of FLT3-ITD-positive AML
    Charlet, Anne
    Kappenstein, Max
    Keye, Philip
    Klasener, Kathrin
    Endres, Cornelia
    Poggio, Teresa
    Gorantla, Sivahari P.
    Kreutmair, Stefanie
    Sanger, Jana
    Illert, Anna L.
    Miething, Cornelius
    Reth, Michael
    Duyster, Justus
    Rummelt, Christoph
    von Bubnoff, Nikolas
    LEUKEMIA, 2022, 36 (03) : 701 - 711
  • [6] Activation mechanisms of STAT5 by oncogenic Flt3-ITD
    Choudhary, Chunaram
    Brandts, Christian
    Schwable, Joachim
    Tickenbrock, Lara
    Sargin, Buelent
    Ueker, Andrea
    Boehmer, Frank-D.
    Berdel, Wolfgang E.
    Mueller-Tidow, Carsten
    Serve, Hubert
    BLOOD, 2007, 110 (01) : 370 - 374
  • [7] Context is key for FLT3-ITD
    Meyer, Sara E.
    BLOOD, 2023, 141 (12) : 1373 - 1374
  • [8] Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia
    Park, Jung Eun
    Yuen, Hiu Fung
    Zhou, Jian Biao
    Al-aidaroos, Abdul Qader O.
    Guo, Ke
    Valk, Peter J.
    Zhang, Shu Dong
    Chng, Wee Joo
    Hong, Cheng William
    Mills, Ken
    Zeng, Qi
    EMBO MOLECULAR MEDICINE, 2013, 5 (09) : 1351 - 1366
  • [9] The beta chain of the IL-3 receptor functionally associates with the erythropoietin receptor
    Jubinsky, PT
    Seiff, C
    Nathan, DG
    BLOOD, 1995, 86 (10) : 50 - 50
  • [10] Heterotrimeric G-Proteins Are Indispensable for FLT3-ITD autophosphorylation and Oncogenic Function
    Rehage, Maike
    Wingert, Susanne
    Haetscher, Nadine
    Bothur, Sabrina
    Serve, Hubert
    Grez, Manuel
    Schwaeble, Joachim
    Rieger, Michael A.
    BLOOD, 2016, 128 (22)
12345